A UAMS research team has identified a potential cause of long-lasting symptoms experienced by COVID-19 patients, often referred to as long-haulers. At the heart of the team’s findings is an antibody that shows up weeks after an initial infection and…
Tag:
plasma
- AMP NewsHealth Care
UAMS Receives FDA Authorization to Use Convalescent Plasma as COVID-19 Treatment
by Tyler Haleby Tyler HaleThe University of Arkansas for Medical Sciences (UAMS) has received authorization to use convalescent plasma as an experimental treatment for COVID-19 patients in Arkansas. The Food and Drug Administration (FDA) authorized the use of the experimental treatment, with UAMS serving…